Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.42%

Sanofi (SNY)

-NYSE
50.73 Down 0.52(1.01%) May 22, 4:00PM EDT
Add to Portfolio
Prev Close:51.25
Open:51.08
Bid:50.72 x 800
Ask:50.73 x 300
1y Target Est:56.60
Beta:1.09
Next Earnings Date:N/A
Day's Range:50.65 - 51.08
52wk Range:43.57 - 57.42
Volume:347,000
Avg Vol (3m):1,407,690
Market Cap:132.66B
P/E (ttm):27.80
EPS (ttm):1.83
Div & Yield:1.62 (3.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNYDown 1.01%132.66B
GSKDown 0.66%109.30B
MRKDown 1.20%167.76B
PFEDown 0.23%211.08B

Key Statistics

Forward P/E (1 yr):15.80
P/S (ttm):3.41
Ex-Dividend Date:06-May-15

Analysts

Annual EPS Est (Dec-15) :3.11
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):2.82

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sanofi researches, develops, and markets various therapeutic solutions. Its products comprise diabetes solutions, including Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback